With our advanced therapeutic antibody discovery and development platforms, Creative Biolabs is able to come up with various collaboration-based programs to develop novel candidate biologics with greater therapeutic potentials. We are committed to achieving strategic collaborations with our partners. By building a collaborative, consulting and support relationship, we are hoping to advance cancer immunotherapy together. Learn more: Next-IO™ Anti-CD16 (FcgRIIIA) IgG Program